MONTREAL, 10 de outubro de 2023 /PRNewswire/ — Knight Therapeutics Inc., (TSX: GUD) (“Knight”), uma empresa pan-americana (ex-EUA) de especialidades farmacêuticas, anunciou hoje que sua filial brasileira, a United Medical Ltda., submeteu um pedido de registro junto ANVISA, agência de…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.